GANAVVFFBYPUBU-UHFFFAOYSA-N
C41H30F6N8O3 — CID 135277926
Data last refreshed: (MolForge compound catalog, from PubChem)
About GANAVVFFBYPUBU-UHFFFAOYSA-N
GANAVVFFBYPUBU-UHFFFAOYSA-N (PubChem CID 135277926) has the molecular formula C41H30F6N8O3 and a molecular weight of 796.73 g/mol. Its IUPAC name is 4-methyl-3-[3-[(3-methyl-1H-pyrrole-2-carbonyl)amino]-1-[[4-(trifluoromethyl)phenyl]methyl]indazol-5-yl]-N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]-1,2-oxazole-5-carboxamide.
Molecular Properties
| Compound Name | GANAVVFFBYPUBU-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 135277926 |
| Molecular Formula | C41H30F6N8O3 |
| Molecular Weight | 796.73 g/mol |
| Exact Mass | 796.23 |
| IUPAC Name | 4-methyl-3-[3-[(3-methyl-1H-pyrrole-2-carbonyl)amino]-1-[[4-(trifluoromethyl)phenyl]methyl]indazol-5-yl]-N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]-1,2-oxazole-5-carboxamide |
| SMILES | Cc1cc[nH]c1C(=O)Nc1nn(Cc2ccc(C(F)(F)F)cc2)c2ccc(-c3noc(C(=O)Nc4nn(Cc5ccc(C(F)(F)F)cc5)c5ccccc45)c3C)cc12 |
| InChI | InChI=1S/C41H30F6N8O3/c1-22-17-18-48-33(22)38(56)49-37-30-19-26(11-16-32(30)55(52-37)21-25-9-14-28(15-10-25)41(45,46)47)34-23(2)35(58-53-34)39(57)50-36-29-5-3-4-6-31(29)54(51-36)20-24-7-12-27(13-8-24)40(42,43)44/h3-19,48H,20-21H2,1-2H3,(H,49,52,56)(H,50,51,57) |
| InChIKey | GANAVVFFBYPUBU-UHFFFAOYSA-N |
| XLogP | 9.62 |
| TPSA | 135.66 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 796.73 |
| LogP ≤ 5 | 9.62 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135277926 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.